The top drug reg­u­la­tor at the FDA is re­tir­ing, ac­cord­ing to an email re­viewed by End­points News and con­firmed by sev­er­al in­di­vid­u­als with­in the agency. Jacque­line Cor­ri­g­an-Cu­ray, who’s been at the FDA's Cen­ter for Drug Eval­u­a­tion and Re­search for more than eight years, said in a note to staff that she has de­cid­ed to re­tire in Ju­ly...